menu
    • menu

    Company profile for Ajax Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Advances in molecular genetics and biology have led to the development of new classes of targeted therapies for the treatment of hematologic malignancies. However, many of these therapies, while selective for a particular drug target, often interact with other related proteins which can limit their efficacy and lead to unwanted side effects. At Ajax, we are targeting hematologic malignancies with greater precision by applyin...
    Advances in molecular genetics and biology have led to the development of new classes of targeted therapies for the treatment of hematologic malignancies. However, many of these therapies, while selective for a particular drug target, often interact with other related proteins which can limit their efficacy and lead to unwanted side effects. At Ajax, we are targeting hematologic malignancies with greater precision by applying state-of-the-art computational chemistry and structural biology throughout the drug discovery and development process to create best-in-class therapies for significant unmet medical needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ajax TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge, Massachusetts
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ajaxtherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ajax Therapeutics Granted U.S. FDA Orphan Drug Status
    Ajax Therapeutics Granted U.S. FDA Orphan Drug Status

    10 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/10/3203086/0/en/Ajax-Therapeutics-Receives-Orphan-Drug-Designation-from-the-U-S-FDA-for-AJ1-11095-for-the-Treatment-of-Myelofibrosis.html

    GLOBENEWSWIRE
    10 Dec 2025
    Share Share
    Ajax Therapeutics Names David Waller as Senior VP and Head of CMC
    Ajax Therapeutics Names David Waller as Senior VP and Head of CMC

    19 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/19/3135629/0/en/Ajax-Therapeutics-Appoints-David-Waller-PhD-as-Senior-Vice-President-and-Head-of-CMC.html

    GLOBENEWSWIRE
    19 Aug 2025
    Share Share
    Ajax Therapeutics, Schrödinger Expand JAK Research Partnership
    Ajax Therapeutics, Schrödinger Expand JAK Research Partnership

    17 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250717399124/en/Ajax-Therapeutics-and-Schrdinger-Expand-Research-Collaboration-to-Include-Additional-JAK-Target

    BUSINESSWIRE
    17 Jul 2025
    Share Share
    Ajax to Present Phase 1 Data for AJ1?11095 in Myelofibrosis at ASH
    Ajax to Present Phase 1 Data for AJ1?11095 in Myelofibrosis at ASH

    02 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241202135124/en

    BUSINESSWIRE
    02 Dec 2024
    Share Share
    Ajax Therapeutic Doses 1st Patient in Phase 1 JAK2 Inhibitor Trial
    Ajax Therapeutic Doses 1st Patient in Phase 1 JAK2 Inhibitor Trial

    30 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241030209939/en

    BUSINESSWIRE
    30 Oct 2024
    Share Share
    Ajax Therapeutics Gets FDA IND Clearance For JAK2 Inhibitor In Myelofibrosis
    Ajax Therapeutics Gets FDA IND Clearance For JAK2 Inhibitor In Myelofibrosis

    13 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240513313466/en

    BUSINESSWIRE
    13 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search